Riociguat

CAS 625115-55-1 7 current recordsSmall Molecule

Who holds supplier records for Riociguat? 7 organisations hold a current record for Riociguat: an active US FDA Type II Drug Master File or a CEP. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Riociguat: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/riociguat

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    5 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Riociguat expires 18 Feb 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Riociguat. Country is the organisation's recorded country, not necessarily the manufacturing site.

India5China1Country not recorded for 1
Need Riociguat sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Riociguat, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. SanmenCN
CEP 2025-649 - Rev 00
Riociguat
Jun 2026—
MSN LIFE SCIENCES PRIVATE LIMITED MedakIN
CEP 2024-079 - Rev 00
Riociguat, Route code RG, Micronised and Non-Micronised
Jun 2026Inspected Oct 2025
Slovakia
MICRO LABS LIMITED BengaluruIN
CEP 2025-423 - Rev 00
Riociguat, Micronised
Feb 2026—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2023-191 - Rev 00
Riociguat, Modification I, micronised
Feb 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (10 listed products contain Riociguat). The latest listed patent expires 18 Feb 2034. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Riociguat is a soluble guanylate cyclase stimulator that works by increasing the sensitivity of soluble guanylate cyclase to endogenous nitric oxide. It is used in the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Chemical identity

IUPAC name
methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
Canonical SMILES
CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC
InChIKey
WXXSNCNJFUAIDG-UHFFFAOYSA-N
Synonyms
Adempas API, adempas, bay 63-2521, bay-63-2521

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Soluble Guanylate Cyclase Stimulator
Mechanism of action
Guanylate Cyclase Stimulators

Therapeutic areas

Cardiovascular DiseasesPulmonary Hypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Riociguat?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Riociguat: MSN LIFE SCIENCES PRIVATE LIMITED (India), Alembic Pharmaceuticals Limited (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), HONOUR LAB LTD (India), ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD, MICRO LABS LTD (India) and Zhejiang Hengkang Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Riociguat Drug Master Files are active?

MSN LIFE SCIENCES PRIVATE LIMITED (DMF 38372, 31092), Alembic Pharmaceuticals Limited (DMF 31665), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 42349), HONOUR LAB LTD (DMF 42240) and ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD (DMF 43320). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Riociguat have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Riociguat on the EDQM register, including ZHEJIANG HENGKANG PHARMACEUTICAL CO., LTD. Sanmen (CN), MSN LIFE SCIENCES PRIVATE LIMITED Medak (IN), MICRO LABS LIMITED Bengaluru (IN) and ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Riociguat?

Yes. The latest patent listed for an approved US product containing Riociguat expires 18 Feb 2034, across 10 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Riociguat supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Riociguat?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.